Prokidney

PROKNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$322.025 M

$1.07 -4.91%

Close of 6 Nov 2026

As of 6 Nov 2026, Prokidney (PROK) has a market capitalization of $322.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$69.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#77AgomAb TherapeuticsAGMB$332.4M
#78Fennec PharmaceuticalsFENC$327.6M
#79ProkidneyPROK$322.0M
#80Eikon TherapeuticsEIKN$315.8M
#81X4 PharmaceuticalsXFOR$314.0M

What if Prokidney were worth as much as…

Open the what-if tool →

Gold $28.2T

$93,384.80

Per share 87,685× higher

Bitcoin $1.53T

$5,052.89

Per share 4,744× higher

Apple $5.02T

$16,588.16

Per share 15,576× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Prokidney are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.